Furthermore, NF-κB p65 inhibitor PDTC enhanced the expression of S100B-induced SDF-1α in VSMCs, which was different from the role of activated NF-κB p65 by RAGE in inducing SDF-1α expression in the diabetic kidney [36]. Here, S100B is linked to urogenital neoplasm.